Efficacy and safety of metoprolol in the treatment of doxorubicin-induced cardiomyopathy in pediatric patients

American Heart Journal

Volumn 129, Issue 1, 1995, Pages 197-199

  Shaddy, Robert E ^a   Olsen, Stephanie L ^a   Bristow, Michael R ^a   Taylor, David O ^a   Bullock, Emily A ^a   Tani, Lloyd Y ^a   Renlund, Dale G ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; METOPROLOL;

ADOLESCENT; ARTICLE; CARDIOMYOPATHY; CASE REPORT; CHILDHOOD CANCER; DRUG EFFICACY; DRUG SAFETY; HUMAN; PRIORITY JOURNAL;

ADOLESCENT; CASE REPORT; CHILD; DOXORUBICIN; HEART FAILURE, CONGESTIVE; HUMAN; MALE; METOPROLOL; REMISSION INDUCTION; TIME FACTORS;

EID: 0028831937     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/0002-8703(95)90061-6     Document Type: Article

References (6)

1. Clinical spectrum of anthracycline antibiotic cardiotoxicity
2. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood
3. Congestive heart failure due to adriamycin cardiotoxicity: its natural history in children
4. Increased β-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy
5. Pathophysiologic and pharmacologic rationales for clinical management of chronic heart failure with beta-blocking agents
6. Reversibility of severe left ventricular dysfunction due to doxorubicin cardiotoxicity